The "Deemed To Be a License" Provision of the BPCI Act; Questions and Answers; Guidance for Industry
Details
The document's own metadata, straight from the source system.
- Title
- The "Deemed To Be a License" Provision of the BPCI Act; Questions and Answers; Guidance for Industry
- Posted
- Mar 5, 2020
- Comment period
- Mar 5, 2020 – ?
- Topics
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Campaigns
Organized form-letter drives, separated from organic one-off comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jun 10, 2026Comment from Whitney DeFoorOpposeIndividual
An individual patient expresses opposition to the reclassification of desiccated thyroid extract (DTE) as a biologic. They argue that this change creates unnecessary barriers to access, threatens the role of compounding pharmacies, and will lead to higher costs and fewer treatment options for patients who do not respond well to synthetic medicines.
Read comment → - Jun 10, 2026Comment from Renee JohnsonOpposeIndividual
An individual patient expresses opposition to the reclassification of desiccated thyroid extract (DTE) as a biologic. They argue that this change creates unnecessary barriers to access, threatens the role of compounding pharmacies, and will lead to higher costs and fewer treatment options for patients who do not respond well to synthetic medicines.
Read comment → - Jun 10, 2026Comment from kathleen PlummerOpposeIndividual
An individual patient expresses opposition to the reclassification of desiccated thyroid extract (DTE) as a biologic. They argue that this change creates unnecessary barriers to access, threatens the role of compounding pharmacies, and will lead to higher costs and fewer treatment options for patients who do not respond well to synthetic medicines.
Read comment → - Jun 9, 2026Comment from karen declouetOpposeIndividual
An individual patient expresses opposition to the reclassification of desiccated thyroid extract (DTE) as a biologic. They argue that this change creates unnecessary barriers to access, threatens the role of compounding pharmacies, and will lead to higher costs and fewer treatment options for patients who do not respond well to synthetic medicines.
Read comment → - Jun 9, 2026Comment from Jacy GuidryOpposeIndividual
An individual patient expresses opposition to the reclassification of desiccated thyroid extract (DTE) as a biologic. They argue that this change creates unnecessary barriers to access, threatens the role of compounding pharmacies, and will lead to higher costs and fewer treatment options for patients who do not respond well to synthetic medicines.
Read comment → - Jun 9, 2026Comment from Eric MillerOpposeIndividual
An individual patient expresses opposition to the reclassification of desiccated thyroid extract (DTE) as a biologic. They argue that this change creates unnecessary barriers to access, threatens the role of compounding pharmacies, and will lead to higher costs and fewer treatment options for patients who do not respond well to synthetic medicines.
Read comment → - Jun 9, 2026Comment from Allison CraigOpposeIndividual
An individual patient expresses opposition to the reclassification of desiccated thyroid extract (DTE) as a biologic. They argue that this change creates unnecessary barriers to access, threatens the role of compounding pharmacies, and will lead to higher costs and fewer treatment options for patients who do not respond well to synthetic medicines.
Read comment → - Jun 9, 2026Comment from Crystal JeansonneOpposeIndividual
An individual patient expresses opposition to the reclassification of desiccated thyroid extract (DTE) as a biologic. They argue that this change creates unnecessary barriers to access, threatens the role of compounding pharmacies, and will lead to higher costs and fewer treatment options for patients who do not respond well to synthetic medicines.
Read comment → - Jun 9, 2026Comment from Danica MeadOpposeIndividual
An individual patient expresses opposition to the reclassification of desiccated thyroid extract (DTE) as a biologic. They argue that this change creates unnecessary barriers to access, threatens the role of compounding pharmacies, and will lead to higher costs and fewer treatment options for patients who do not respond well to synthetic medicines.
Read comment → - Jun 9, 2026Comment from rosemary cohoonOpposeIndividual
An individual patient expresses opposition to the reclassification of desiccated thyroid extract (DTE) as a biologic. They argue that this change creates unnecessary barriers to access, threatens the role of compounding pharmacies, and will lead to higher costs and fewer treatment options for patients who do not respond well to synthetic medicines.
Read comment →